Photo: Getty Images
Here's Today's Feel-Good Story:
A new blood test for ovarian cancer is on the horizon due to a discovery of three telltale proteins.
The hope is that people will be able to be diagnosed earlier because "the silent killer" cancer only usually shows symptoms after it spread.
“The results of this research suggest that these diagnostic biomarkers can be used as predictive markers for specific therapies,” said lead author Dr. Akira Yokoi, of Nagoya University.
“Our results allow doctors to optimize their therapeutic strategy for ovarian cancer, therefore, they may be useful for realizing personalized medicine.”